dr. flinn on toxicities with venetoclax plus obinutuzumab in cll
Published 6 years ago • 214 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:13
dr. flinn on next steps with venetoclax plus obinutuzumab in cll
-
3:52
dr. flinn on venetoclax and obinutuzumab in cll
-
1:11
dr. flynn on obinutuzumab for the treatment of cll
-
1:01
dr. abedin on the role of venetoclax plus obinutuzumab in cll
-
1:02
dr. gerson on venetoclax/obinutuzumab combination in cll
-
5:54
cll14: venetoclax plus obinutuzumab for cll
-
8:16
venetoclax and obinutuzumab in cll
-
0:43
ideal patient for venetoclax/obinutuzumab combination | dr. jeff sharman | oncology brothers #2023
-
9:15
obinutuzumab venetoclax for frontline cll
-
5:12
cll14: venetoclax plus obinutuzumab in untreated cll
-
1:25
dr. rogers discusses obinutuzumab, ibrutinib, and venetoclax combination in cll
-
2:29
the efficacy & toxicity of venetoclax-based combination therapies in cll
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
0:56
dr. chavez discusses ibrutinib plus venetoclax in cll
-
3:53
the safety and efficacy of venetoclax/obinutuzumab combo in cll
-
0:19
copy of dr. abedin on the role of venetoclax plus obinutuzumab in cll
-
0:56
dr. al-sawaf on continual mrd assessment after venetoclax/obinutuzumab in cll
-
10:24
fixed-duration therapy with venetoclax-obinutuzumab in frontline cll
-
3:15
overview of a phase ib study of venetoclax and obinutuzumab in cll